Delphi Pharma delivers measurable
results to its clients in order to provide an established framework for
strategic decision-making
Discounted cash flow: NPV, ENPV
Which pipeline compounds have the greatest potential value?
What is the expected risk-adjusted compound value?
Which actionable development recommendation has the greatest
potential impact on value?
Which compounds are of greatest value to the organization as
a whole when adjusted for shareholders' expected rate of return?
Project evaluation: real options, Monte Carlo simulation
How can product value be measured accounting for market
risk?
How can the strategic value of development stop/go decisions
be measured ?
What payment structure most closely reflects the true
compound value and risks to the organization as a whole?
Market simulation: attribute-based product forecasting
How will prescribers react to given product profile?
What are the key product attributes driving prescribing?
What is the price sensitivity with respect to efficacy in a
given product market?
Decision-making applications: ROI, promotional effectiveness
What are the net returns from a switch to OTC?
What are the marginal returns from physician detailing
visits, and how can promotional effectiveness be maximized?
Should a compound be developed and marketed in-house or
out-licensed?
Independent Strategic Decision
Analysis 
